When compared to CA 19-9, which had a 36% sensitivity to detect cancer within 18 months before the diagnosis of PDAC, the APO isoform, along with CA 19-9, had an improved sensitivity of 43% at 98% specificity. The gene discussed is AOPEP; the disease is cancer.